Navigation Links
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
Date:4/22/2009

    BEIJING, April 22 /PRNewswire-Asia-FirstCall/ --

    -- Revenues of $73.8 million
    -- Gross Profit of $33.4 million
    -- Net income of $12.8 million or $0.27 per diluted share

Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS, "Lotus" or the "Company") today reported its strong 2008 results with total net revenues increasing to $73.8 million, up 30% from 2007 total net revenues; gross profit increasing to $33.4 million, up 44% over 2007 gross profit of $23.2 million; net income $12.8 million or $0.27 diluted earnings per share, compared to net income of $11.2 million, or diluted earnings per share of $0.26, in 2007.

"We achieved substantially all of our goals for 2008. We exceeded the 'make good' net income and remain on track to meet the 2009 full-year goal," stated Dr. Zhongyi Liu, Chairman and CEO of Lotus. "We've also focused our expansion into Inner Mongolia with plans of new revenue lines, and as we establish these lines through 2009 till 2011 we are positioning ourselves for ambitious growth starting from 2011 and beyond, while maintaining steady growth from 2009 to 2011.

"Gross profit growth has been strong and we believe has proven our business model's resilience in the current global and local economic climate. We believe our business model can weather market and economic storms as it is supported by the diversification in revenues generated from prescription drugs ranging from self-produced and self-branded to third party manufactured, from retail sales of OTC drugs and from manufacturing and R&D for third party customers; Additionally, we believe we continuously make our operation more efficient and position Lotus to benefit from preferential tax policies offered in Inner Mongolia. Once our plant in Inner Mongolia begins to run at full production capacity, which we believe will be in 2013, we could save at least $15.5 million from significantly reduced taxes
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
3. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... ... August 05, 2015 , ... Hotze ... industry, is pleased to announce that it has added Electronic Beam Computed Tomography ... The scanner will be used primarily for conducting coronary artery scans and ...
(Date:8/5/2015)... ... ... the makers of the nation’s leading line of recovery drinks, has answered consumers’ calls once ... brew is smooth, rich and ready to travel, in three flavors. It tastes awesome because ... need milk and sugar to taste great like other traditional ready to drink coffees. ...
(Date:8/5/2015)... ... August 05, 2015 , ... Optimized Care Network (OCN) will join providers ... provide more patient choice during the first-ever Convenient Healthcare and Pharmacy Collaborative, Aug. 6-7. ... the challenges confronting retail clinics, how to expand their role and future trends in ...
(Date:8/5/2015)... ... 05, 2015 , ... i2i Systems announces the appointment of ... Systems team during a period of growth and platform expansion, driven by the ... to new shared-risk models that support enhanced clinical and financial outcomes and profitable ...
(Date:8/5/2015)... ... 05, 2015 , ... "Art de Toilettes" , It all ... suggest ideas to add some fun and visual interest to the company lobby. ... transform toilets into works of art. Renew Life makes natural digestive care supplements ...
Breaking Medicine News(10 mins):Health News:Hotze Health & Wellness Center Adds EBCT Imaging Services to Preventative Screening Program 2Health News:Hotze Health & Wellness Center Adds EBCT Imaging Services to Preventative Screening Program 3Health News:Kill Cliff® Releases Epic New Product Line – Coffeehouse Quality Cold Brew Coffee in a Can 2Health News:Optimized Care Network Joins First-ever Convenient Healthcare and Pharmacy Collaborative 2Health News:Optimized Care Network Joins First-ever Convenient Healthcare and Pharmacy Collaborative 3Health News:i2i Systems Hires Healthcare Industry Authority Justin L. Neece as Chief Operations Officer 2Health News:Fantastic Team Spirit and Creativity Prevailed at Renew Life “Art de Toilettes” 2
... ... ... , , ... WASHINGTON , Feb. 25 ...
... ... ... ... ...
... ... ... , , , ... ...
... , , ... ... ... ...
... policymakers make reasonable decisions when they have limited ... Charles F. Manski explores in his new paper, ... paper is published online by the Proceedings ... at http://www.pnas.org/content/early/2010/02/05/0915009107.full.pdf+html . "Let,s say you,re ...
... by Johns Hopkins say they have identified the mechanisms rooted ... of schizophrenia and the reason symptoms don,t develop until young ... gene known as DISC1, whose mutant form was first identified ... and related mental disorders. The findings could lead to new ...
Cached Medicine News:Health News:NORD Calls FDA Action 'An Important Advance for Patients' 2Health News:NORD Calls FDA Action 'An Important Advance for Patients' 3Health News:LodgeNet Interactive Names Frank P. Elsenbast As Next Chief Financial Officer 2Health News:LodgeNet Interactive Names Frank P. Elsenbast As Next Chief Financial Officer 3Health News:LodgeNet Interactive Names Frank P. Elsenbast As Next Chief Financial Officer 4Health News:NSBA Implores Congress to Act on Health Care Reform 2Health News:NSBA Implores Congress to Act on Health Care Reform 3Health News:Approval of Kansas Smoke-Free Legislation Is Historic Win for Health 2Health News:Approval of Kansas Smoke-Free Legislation Is Historic Win for Health 3Health News:Approval of Kansas Smoke-Free Legislation Is Historic Win for Health 4Health News:Approval of Kansas Smoke-Free Legislation Is Historic Win for Health 5Health News:How can policymakers cope with ambiguity? 2Health News:Why symptoms of schizophrenia emerge in young adulthood 2Health News:Why symptoms of schizophrenia emerge in young adulthood 3
(Date:8/5/2015)...  GSI Group Inc. (NASDAQ: GSIG ) (the "Company", ... precision motion, and vision technologies to original equipment manufacturers in ... for the second quarter of 2015.Financial HighlightsThree Months Ended(In millions, ... , $ , 96.5 $ ... $ , 10.3 $ , ...
(Date:8/5/2015)... 2015  Innovative therapies that transform quickly progressing, ... – into manageable, chronic conditions offer great hope ... however, they present pharmaceutical companies with unusual drug ... and marketing decisions based on a patient population ... new methods of collecting and analyzing complex clinical, ...
(Date:8/5/2015)... WESTLAKE VILLAGE, Calif. , Aug. 5, ... and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) today ... agreement with respect to Allergan,s pending acquisition of KYTHERA ... agreement amends and restates the original merger agreement entered ... amended on July 1, 2015. Logo - ...
Breaking Medicine Technology:GSI Group Announces Financial Results for the Second Quarter of 2015 2GSI Group Announces Financial Results for the Second Quarter of 2015 3GSI Group Announces Financial Results for the Second Quarter of 2015 4GSI Group Announces Financial Results for the Second Quarter of 2015 5GSI Group Announces Financial Results for the Second Quarter of 2015 6GSI Group Announces Financial Results for the Second Quarter of 2015 7GSI Group Announces Financial Results for the Second Quarter of 2015 8GSI Group Announces Financial Results for the Second Quarter of 2015 9GSI Group Announces Financial Results for the Second Quarter of 2015 10GSI Group Announces Financial Results for the Second Quarter of 2015 11GSI Group Announces Financial Results for the Second Quarter of 2015 12GSI Group Announces Financial Results for the Second Quarter of 2015 13GSI Group Announces Financial Results for the Second Quarter of 2015 14GSI Group Announces Financial Results for the Second Quarter of 2015 15GSI Group Announces Financial Results for the Second Quarter of 2015 16GSI Group Announces Financial Results for the Second Quarter of 2015 17GSI Group Announces Financial Results for the Second Quarter of 2015 18GSI Group Announces Financial Results for the Second Quarter of 2015 19GSI Group Announces Financial Results for the Second Quarter of 2015 20GSI Group Announces Financial Results for the Second Quarter of 2015 21GSI Group Announces Financial Results for the Second Quarter of 2015 22GSI Group Announces Financial Results for the Second Quarter of 2015 23GSI Group Announces Financial Results for the Second Quarter of 2015 24GSI Group Announces Financial Results for the Second Quarter of 2015 25GSI Group Announces Financial Results for the Second Quarter of 2015 26New analytics improve pharmaco strategic decision-making for some deadly diseases 2New analytics improve pharmaco strategic decision-making for some deadly diseases 3Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 2Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 3Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 4Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 5Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 6Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 7Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 8
... ORLANDO, Florida and MELBOURNE, Australia, November 14, 2011 ... Mesenchymal Precursor Cell (MPC) product for cardiovascular diseases, was safe ... responses to donor cells , , ... events (MACE) in patients with congestive heart failure over a ...
... Fla., Nov. 14, 2011 Patients ... stroke and blood clots, failed to remain on the treatment ... according to a study presented at the American Heart Association,s ... The research conducted by Medco Research Institute™, a subsidiary ...
Cached Medicine Technology:Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting 2Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting 3Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting 4Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk 2Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk 3Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk 4
... the pioneers of surgical lighting, including ... automatic reserve bulb, an integrated surgical ... sets the standard for advanced lighting ... our latest generation surgical light ...
... SimpliCT® is an interventional guidance device ... significantly improve the accuracy of computed ... to improving accuracy, SimpliCT® also has ... of CT-guided puncture procedures including biopsies ...
Flat tip, bare fiber, no cooling, polished SMA 905, 3 meters long. Sold in boxes of five. Each part is individually packaged in sterile Tyvek bags....
Get YAG laser performance from your diode laser. Our proprietary NA shift technology offers efficient coupling of low divergence fiber to high divergence lasers...
Medicine Products: